cilostazol has been researched along with ferric chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurimoto, T; Sato, R; Tanaka, T | 1 |
| Bae, IH; Chung, JH; Jeong, YS; Kim, CW; Lim, KM; Park, JW; Park, YH; Yun, JW | 1 |
2 other study(ies) available for cilostazol and ferric chloride
| Article | Year |
|---|---|
Z-335, a new thromboxane A(2) receptor antagonist, prevents arterial thrombosis induced by ferric chloride in rats.
Topics: Administration, Oral; Animals; Aorta, Abdominal; Chlorides; Cilostazol; Dose-Response Relationship, Drug; Ferric Compounds; Fibrinolytic Agents; Indans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Tetrazoles; Thrombosis; Time Factors | 2000 |
Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo.
Topics: Animals; Blood Platelets; Chlorides; Cilostazol; Ferric Compounds; Fibrinolytic Agents; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Rats; Rats, Sprague-Dawley; Tetrazoles; Thrombosis | 2011 |